
María Cañadas Granados
Médico Adjunto- Urología
- Hospital Universitario Fundación Jiménez Díaz
Residency in Urology (MIR) at Hospital Universitario Virgen de Valme (2016-2021)
Consultant Urologist at Fundación Jiménez Díaz University Hospital (2021-present)
Degree in Medicine and Surgery. Completed in 2015
Master's Degree in Uro-Oncology, Universidad Cardenal Herrera (CEU)
Master's Degree in Multidisciplinary Management of Prostate Cancer, Universidad Autónoma de Madrid
Renal and pelvic laparoscopy
Endourology
Penile and testicular surgery
PhD candidate, Official Doctoral Program, Universidad Autónoma de Madrid
Sub-Investigator in Clinical Trial ALBAN: An open label, randomized, phase III trial, evaluating efficacy of Atezolizumab in addition to one year BCG (Bacillus CaLmetteGuerin) bladder instillation in BCG-naive patients with high-risk non-muscle invasive Bladder cANcer UNICANCER Group Tumor: GETUG / AFU. 2022-01/01/2027.
Sub-Investigator in Clinical Trial ENCORE-01: Phase IIb Clinical Trial: Treatment of high-risk non-muscle infiltrating bladder tumors with IMUNO BCG Moreau RJ as prophylaxis for recurrence and progression Biofabri/FIU.
Sub-Investigator in Clinical Trial ENVISION: A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients with Low Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence UroGen Pharma Ltd. 2022-01/01/2027.
Sub-Investigator in Clinical Trial URANUS TRIAL: Neo-adjuvant versus Adjuvant chemotherapy in Upper tract Urothelial Carcinoma: A feasibility phase II randomizec clinical Trial EUOG (European Uro-oncology Group).
Clínico Colaborador Docente en Facultad de Medicina de la Universidad Autónoma de Madrid
Profesor Facultad de Medicina de la Universiad Alfonso X
García-Mejido JA, Bonomi-Barby MJ, Armijo-Sánchez A, Borrero-Fernández C, Castro-Portillo L, Vargas-Broquetas M, Cañadas-Granados M, Sainz-Bueno JA. Methodology for the transperineal ultrasound imaging of the pelvic floor. Clin Invest Gin Obst. 2020. doi:10.1016/j.gine.2020.09.008.
Pérez-Aizpurua X, Monzó-Gardiner JI, Popescu OB, Buendía-González E, Cuello- Sánchez L, Cañadas-Granados M, Tufet i Jaumot JJ, Ruiz de Castroviejo-Blanco J, Osorio-Ospina F, Cabello-Benavente R, González-Enguita C.. A systematic review on the current landscape of T1 bladder cancer substaging. Urology. 2024;194:310-326. doi:10.1016/j.urology.2024.10.013.
Management of refractory overactive bladder. Book chapter.
Hospital Universitario Fundación Jiménez Díaz
Avda. Reyes Católicos, 2
28040 Madrid Madrid
© 2025 Quirónsalud - All rights reserved